Merck
CN
Search Within

252-170-2

Applied Filters:
Keyword:'252-170-2'
Showing 1-4 of 4 results for "252-170-2" within Papers
Dhani Raj Chhetri et al.
Applied biochemistry and biotechnology, 167(8), 2269-2282 (2012-06-19)
L-myo-inositol-1-phosphate synthase (MIPS; EC: 5.5.1.4) activity has been detected and partially purified for the first time from human fetal liver. Crude homogenate from the fetal liver was subjected to streptomycin sulphate precipitation and 0-60 % ammonium sulphate fractionation followed by
O Rollman et al.
Archives of dermatological research, 278(1), 17-24 (1985-01-01)
The vitamin-A status of 107 patients with psoriasis and 37 healthy controls was investigated. The mean serum level of retinol-binding protein (RBP) was normal in the 79 patients with chronic plaque psoriasis covering 25% or less of the skin surface.
Maria G V Gottlieb et al.
Genetics and molecular research : GMR, 4(4), 691-703 (2006-02-14)
Oxidized LDL (ox-LDL) is involved in the initiation and progression of atherosclerosis. Many factors can affect the LDL oxidation such as oxidative stress. The present study tested whether ox-LDL levels would be associated with apolipoprotein E (APOE), manganese superoxide dismutase
Jelena S Rudic et al.
The Cochrane database of systematic reviews, 12, CD000551-CD000551 (2012-12-14)
Ursodeoxycholic acid is administered to patients with primary biliary cirrhosis, a chronic progressive inflammatory autoimmune-mediated liver disease with unknown aetiology. Despite its controversial effects, the U.S. Food and Drug Administration has approved its usage for primary biliary cirrhosis. To assess
Page 1 of 1